Steve Jobs Would Have Loved ‘Vision Pro,’ His Biographer Says
Walter Isaacson, biographer of the late Apple Inc (NASDAQ:AAPL) CEO and co-founder Steve Jobs, firmly believes Jobs would…
Alphabet, Meta, Pinterest, And Snap Shares Catch Attention As New Coverage Initiated By Analysts
Large and mid-cap tech companies, specifically shares of Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL), Meta Platforms Inc (NASDAQ:META), Pinterest Inc…
Bunge Nears $30B Plus Merger Deal With Viterra: Report
Bunge Ltd (NYSE: BG) is nearing the merger deal with Glencore PLC (OTC: GLNCY) Viterra grains division.
Toyota Invests $50M To Boost EV Capability In The US
Toyota Motor Corp (NYSE: TM) disclosed an investment of around $50 million to build a new laboratory facility at
Ad-Supported Prime Video And Positive Analyst Coverage Drive Amazon Shares Higher
Shares of Amazon.com, Inc (NASDAQ:AMZN) are moving to the upside by more than 3% Thursday after a report issued by The Wall Street Journal suggests that the company is seeking to launch an advertising
Morgan Stanley and JPMorgan Review Ties with Odey Asset Management Amid Sexual Assault Allegations
Fresh allegations against Crispin Odey concerning sexual assault against women have been published. JPMorgan Chase & Co (NYSE: JPM) and Morgan Stanley (NYSE: MS) started dista
Why Toro Shares Are Sliding Today
The Toro Co (NYSE: TTC) reported a Q2 FY23 sales growth of 7% Y/Y to $1.34 billion, missing
Novartis’ Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
Novartis AG's (NYSE: NVS) generics unit Sandoz tells investors it can add $3 billion in annual sales over the next five years from launching new products after it spins out of its
Hedge Funds Buck Trend In AI Investing, Nvidia Not Their First Choice
AI has recently become a dominant topic in business and tech sectors. With its entry into the mainstream…
British Government Launches Pilot Program For Weight-Loss Shots To Tackle Shortage Of Novo Nordisk’s Wegovy
The British government is set to launch a pilot program to explore the use of new weekly weight-loss shots, such as Novo Nordisk A/S's (NYSE: NVO) Wegovy (semaglutide), for obese patients outside of specialized services.